Regulatory Filings • Mar 22, 2018
Regulatory Filings
Open in ViewerOpens in native device viewer

Tel Aviv, Israel, March 22, 2018, Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today, further to its press release dated November 16, 2016, which stated that Elbit Plaza India Real Estate Holdings Limited ("EPI") (a jointly controlled subsidiary in which the Company holds a 50% stake alongside its subsidiary, Plaza Centers N.V. ("Plaza")), signed a revised agreement in relation to the sale of a 100% interest in a Special Purpose Vehicle ("SPV") which holds a site in Bangalore, India to a local investor (the "Purchaser"), and further to its press releases dated January 19, 2018 and February 21, 2018, that:
Elbit Imaging Ltd. operates in the following principal fields of business: (i) Plaza Centers N.V. operated in the field of development of shopping and entertainment centers in emerging markets, and currently its main focus is to reduce its debt by early repayments following sale of assets; (ii) medical industries and devices for: (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment; and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; and (iii) land in India designated for sale to residential projects.
CEO & Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050 [email protected]

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.